Related Experiment Video
Updated: Aug 15, 2026

In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology
Published on: September 29, 2023
The Novartis compound archive -- from concept to reality
U Schopfer1, C Engeloch, J Stanek
1Compound Logistics and Properties Unit/ Novartis Compound Archive, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland. ulrich.schopfer@novartis.com
Abstract:
As HTS technologies come of age, pharmaceutical companies are focusing increasingly on the quality of their screening collections. Storage conditions and their influence on compound stability and solubility are debated intensely. At Novartis, a strategy was developed that is different to most other companies: (1) compounds unsuitable for storage in solution are excluded by computational methods; (2) compounds are stored at 4 degrees C/20% relative humidity in a DMSO/water mixture to avoid freeze-thaw cycles and water uptake and to allow rapid plate replication; (3) resolubilisation of compounds at regular intervals.
Related Concept Videos
Drug Discovery: Overview
Preclinical Development: Overview
Drug Products: Biologics, Biosimilars and Interchangeables
Clinical Trials: Overview
Modified-Release Drug Delivery Systems: Overview
In Vitro Drug Release Testing: Overview, Development and Validation
